Before Newman, Linn, and Dyk. Appeal from the United States District Court for the District of Oregon.
Summary: The Trademark Act’s definition of “use in commerce” as a requirement for obtaining a federal trademark does...more
Federal Circuit Summary -
Before Moore, Chen, and Hughes. Appeal from the United States District Court for the District of Delaware.
Summary: Obviousness-type double patenting does not invalidate an otherwise validly...more
12/14/2018
/ Abbreviated New Drug Application (ANDA) ,
Appeals ,
Double Patent ,
Judgment on the Pleadings ,
Novartis ,
Obviousness ,
Obviousness-Type Double Patenting (ODP) ,
Patent Expiration ,
Patent Filings ,
Patent Infringement ,
Patent Invalidity ,
Patent Term Adjustment ,
Patent Term Extensions ,
Patent Terms ,
Patents ,
Pharmaceutical Patents ,
Uruguay Round Agreements Act (URAA)
Federal Circuit Summary -
Before Prost, Bryson, and O’Malley. Appeal from the United States International Trade Commission (“ITC”).
Summary: Evidence intrinsic to a patent may be sufficient to overcome the presumption...more
8/21/2018
/ Appeals ,
Evidence ,
Extrinsic Evidence ,
Indefiniteness ,
International Trade Commission (ITC) ,
Means-Plus-Function ,
Patent Infringement ,
Patent Invalidity ,
Patents ,
Rebuttable Presumptions ,
Reversal ,
Section 112 ,
Section 337
Federal Circuit Summaries -
Before Newman, Lourie, and Reyna. Appeal from the United States District Court for the Northern District of Florida.
Summary: Collateral estoppel does not apply to a prior decision of no...more